WallStreetZenWallStreetZen

NASDAQ: AZTA
Azenta Inc Stock

$67.30+2.15 (+3.3%)
Updated Mar 1, 2024
AZTA Price
$67.30
Fair Value Price
-$8.00
Market Cap
$3.75B
52 Week Low
$36.01
52 Week High
$69.16
P/E
-203.94x
P/B
1.54x
P/S
5.76x
PEG
N/A
Dividend Yield
N/A
Revenue
$641.02M
Earnings
-$18.75M
Gross Margin
39.1%
Operating Margin
-4.97%
Profit Margin
-2.9%
Debt to Equity
0.16
Operating Cash Flow
$71M
Beta
1.47
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

AZTA Overview

Azenta, Inc. provides life science sample exploration and management solutions for the life sciences market in North America, Europe, China, the Asia Pacific, and internationally. The company operates through two reportable segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated cold sample management systems for compound and biological sample storage; equipment for sample preparation and handling; consumables; and instruments that help customers in managing samples throughout their research discovery and development workflows. The Life Sciences Services segment provides comprehensive sample management programs, integrated cold chain solutions, informatics, and sample-based laboratory services to advance scientific research and support drug development. This segment's services include sample storage, genomic sequencing, gene synthesis, laboratory processing, laboratory analysis, biospecimen procurement, and other support services. It serves a range of life science customers, including pharmaceutical companies, biotechnology companies, biorepositories, and research institutes. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Chelmsford, Massachusetts.

Zen Score

Industry Average (30)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how AZTA scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

AZTA ($67.30) is overvalued by 941.38% relative to our estimate of its Fair Value price of -$8.00 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
AZTA ($67.30) is not significantly undervalued (941.38%) relative to our estimate of its Fair Value price of -$8.00 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
AZTA is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 35 more AZTA due diligence checks available for Premium users.

Be the first to know about important AZTA news, forecast changes, insider trades & much more!

AZTA News

Valuation

AZTA fair value

Fair Value of AZTA stock based on Discounted Cash Flow (DCF)
Price
$67.30
Fair Value
-$8.00
Undervalued by
941.38%
AZTA ($67.30) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
AZTA ($67.30) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
AZTA is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

AZTA price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-203.94x
Industry
52.57x
Market
36.17x

AZTA price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
1.54x
Industry
3.67x
AZTA is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

AZTA's financial health

Profit margin

Revenue
$154.3M
Net Income
-$15.7M
Profit Margin
-10.2%
AZTA's Earnings (EBIT) of -$31.85M... subscribe to Premium to read more.
Interest Coverage Financials
AZTA's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$2.8B
Liabilities
$380.7M
Debt to equity
0.16
AZTA's short-term assets ($1.38B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
AZTA's short-term assets ($1.38B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
AZTA's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
AZTA's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$26.4M
Investing
$98.4M
Financing
-$113.2M
AZTA's operating cash flow ($70.94M)... subscribe to Premium to read more.
Debt Coverage Financials

AZTA vs Medical Stocks

TickerMarket Cap1d %P/EP/B
AZTA$3.75B+3.30%-203.94x1.54x
HAE$3.77B+1.62%29.66x3.99x
NVST$3.59B+1.31%-34.87x0.86x
MMSI$4.42B+0.08%46.50x3.68x
ICUI$2.54B-3.52%-85.68x1.20x

Azenta Stock FAQ

What is Azenta's quote symbol?

(NASDAQ: AZTA) Azenta trades on the NASDAQ under the ticker symbol AZTA. Azenta stock quotes can also be displayed as NASDAQ: AZTA.

If you're new to stock investing, here's how to buy Azenta stock.

What is the 52 week high and low for Azenta (NASDAQ: AZTA)?

(NASDAQ: AZTA) Azenta's 52-week high was $69.16, and its 52-week low was $36.01. It is currently -2.69% from its 52-week high and 86.89% from its 52-week low.

How much is Azenta stock worth today?

(NASDAQ: AZTA) Azenta currently has 55,765,135 outstanding shares. With Azenta stock trading at $67.30 per share, the total value of Azenta stock (market capitalization) is $3.75B.

Azenta stock was originally listed at a price of $18.13 in Dec 31, 1997. If you had invested in Azenta stock at $18.13, your return over the last 26 years would have been 271.21%, for an annualized return of 5.17% (not including any dividends or dividend reinvestments).

How much is Azenta's stock price per share?

(NASDAQ: AZTA) Azenta stock price per share is $67.30 today (as of Mar 1, 2024).

What is Azenta's Market Cap?

(NASDAQ: AZTA) Azenta's market cap is $3.75B, as of Mar 3, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Azenta's market cap is calculated by multiplying AZTA's current stock price of $67.30 by AZTA's total outstanding shares of 55,765,135.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.